Injection Drug Use and Outcomes After Surgical Intervention for Infective Endocarditis Nabin K. Shrestha, MD, MPH, Jennifer Jue, MD, Syed T. Hussain, MD, Jason M. Jerry, MD, Gosta B. Pettersson, MD, PhD, Venu Menon, MD, Jose L. Navia, MD, Amy S. Nowacki, PhD, Steven M. Gordon, MD The Annals of Thoracic Surgery Volume 100, Issue 3, Pages 875-882 (September 2015) DOI: 10.1016/j.athoracsur.2015.03.019 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier plot for survival free of reoperation for patients who inject drugs and patients who do not. (IDU = injection drug use.) The Annals of Thoracic Surgery 2015 100, 875-882DOI: (10.1016/j.athoracsur.2015.03.019) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Cumulative incidence of death and reoperation for infective endocarditis. (A) Patients who injected drugs and (B) patients who did not inject drugs. The Annals of Thoracic Surgery 2015 100, 875-882DOI: (10.1016/j.athoracsur.2015.03.019) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier plot for overall survival for patients who injected drugs and patients who did not. (IDU = injection drug use.) The Annals of Thoracic Surgery 2015 100, 875-882DOI: (10.1016/j.athoracsur.2015.03.019) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions